Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Corticosteroids in ulcerative colitis: a skeptical view.

R R Babb1

  • 1Palo Alto Medical Clinic, California.

Journal of Clinical Gastroenterology
|August 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Colonic metastases from breast cancer.

Surgical endoscopy·2001
Same author

Recurrent appendicitis. Uncommon, but it does occur.

Postgraduate medicine·1999
Same author

Does this patient have appendicitis?

JAMA·1997
Same author

Radiation proctitis: a review.

The American journal of gastroenterology·1996
Same author

Proctalgia fugax: would you recognize it?

Postgraduate medicine·1996
Same author

Glutaraldehyde proctitis.

The Western journal of medicine·1995

Corticosteroids effectively treat ulcerative colitis, inducing remission in most patients. However, sustained remission remains a challenge, and optimal treatment strategies require further discussion.

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Pharmacology

Background:

  • Corticosteroids have been a cornerstone in ulcerative colitis treatment since 1950.
  • They possess significant anti-inflammatory properties beneficial for managing this condition.

Purpose of the Study:

  • To review the efficacy and limitations of corticosteroid therapy in ulcerative colitis.
  • To discuss the lack of consensus regarding optimal corticosteroid dosing, administration routes, and specific drug choices.

Main Methods:

  • This editorial reviews existing literature and clinical practices regarding corticosteroid use in ulcerative colitis.
  • It synthesizes information on remission rates and treatment sustainability.

Main Results:

Related Experiment Videos

  • Corticosteroids achieve remission in 60-80% of moderately severe and 40-55% of severe ulcerative colitis cases.
  • The success of corticosteroid treatment is often limited by a lack of sustained remission.

Conclusions:

  • While corticosteroids are effective for inducing remission in ulcerative colitis, their long-term efficacy is often compromised.
  • Further research and consensus are needed to define optimal corticosteroid regimens for sustained ulcerative colitis management.